Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01205646
What this trial is testing

PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 11
Testing effectiveness (Phase 2)Looking for participantsNCT06738303
What this trial is testing

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Case Comprehensive Cancer Center 44
Not applicableStudy completedNCT04220983
What this trial is testing

PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Weill Medical College of Cornell University 22
Not applicableStudy completedNCT01118741
What this trial is testing

Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA)

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Early research (Phase 1)Active Not RecruitingNCT01140373
What this trial is testing

Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC)

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT01051570
What this trial is testing

Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 26
Testing effectiveness (Phase 2)Study completedNCT00003259
What this trial is testing

Vinorelbine in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 40
Testing effectiveness (Phase 2)Looking for participantsNCT07751159
What this trial is testing

Radiation Therapy Approaches for People With Prostate Cancer

Who this might be right for
Prostate Cancer PatientsNon-metastatic Prostate CancerHigh Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center 126
Not applicableStudy completedNCT04556045
What this trial is testing

Exercise Therapy and Radiation Therapy (EXERT) for Metastatic Prostate Cancer

Who this might be right for
Malignant Neoplasm of Prostate
Case Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00005028
What this trial is testing

Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 46
Large-scale testing (Phase 3)Study completedNCT00003232
What this trial is testing

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

Who this might be right for
PainProstate CancerQuality of Life
NCIC Clinical Trials Group 227
Early research (Phase 1)Not Yet RecruitingNCT07636707
What this trial is testing

QLF4113 in Participants With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Qilu Pharmaceutical Co., Ltd. 140
Early research (Phase 1)Ended earlyNCT01174199
What this trial is testing

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+2 more
Roswell Park Cancer Institute 13
Not applicableLooking for participantsNCT07004582
What this trial is testing

Lab Research Using Mini-tumors to Study Prostate Cancer Treatments

Who this might be right for
Prostate CancerProstate Cancer Metastatic DiseaseProstate Cancer Recurrent+1 more
Maastricht Radiation Oncology 600
Not applicableUnknownNCT05123391
What this trial is testing

Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate Cancer

Who this might be right for
Prostatic NeoplasmsRadiosurgeryQuality of Life
Pontificia Universidad Catolica de Chile 60
Not applicableLooking for participantsNCT06904625
What this trial is testing

Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer

Who this might be right for
Metastatic Breast CancerMetastatic Prostate Cancer
Institut Claudius Regaud 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07593079
What this trial is testing

Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer

Who this might be right for
Prostate CancerRecurrent Prostate CancerMetastatic Prostate Cancer+2 more
Washington University School of Medicine 20
Testing effectiveness (Phase 2)Ended earlyNCT00494338
What this trial is testing

Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sanofi 6
Not applicableStudy completedNCT02710721
What this trial is testing

Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate Cancer

Who this might be right for
FastingProstatic Neoplasms
Charite University, Berlin, Germany 49
Testing effectiveness (Phase 2)Study completedNCT03554317
What this trial is testing

COMbination of Bipolar Androgen Therapy and Nivolumab

Who this might be right for
Castration-resistant Prostate CancerMetastatic Prostate CancerProstate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45
Next Page